
Umbicell Private Limited
About Umbicell Private Limited
Data last updated:
Umbicell Private Limited is a private limited company based in Thane, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 08 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2017PTC292167. Its GSTIN is 27AACCU0533D1ZS (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nisha Bhagatsingh Rajput and Varun Bhagat Singh Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹48,766 (net margin 0.5%) and EBITDA of ₹1.76 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 45% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Recognitions & Rankings of Umbicell
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo. 5 Shanti Vihar No. C – 3/4 Chsl, Opp. Mira Road Railway Station Mira Road East, Thane, Maharashtra, India – 401107
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Umbicell Private Limited
The main business activity of Umbicell is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Umbicell Private Limited FY 2025 filings available
Umbicell Private Limited reported revenue of ₹1.02 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Umbicell Private Limited
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 45%. EBITDA rose 183% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Umbicell Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹48,766 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Umbicell Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Umbicell are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Umbicell Private Limited
Umbicell has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nisha Bhagatsingh Rajput Also directs: Scigenomics Private Limited, Regibloom Wellness Centre LLP | Director | 16 May 2024 | 2 Years 5 Months | Current |
| Varun Bhagat Singh Singh Also directs: Scigenomics Private Limited | Director | 08 Mar 2017 | 9 Years 7 Months | Current |
Peer Comparison of Umbicell Private Limited
Umbicell Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Human health activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raj Homoeo Hall Private Limited | ₹1.03 Cr (FY 2025) | •••• | •••• | 924.0% | •••• | Tanda, Uttar Pradesh, India |
| Well Care Real Solutions Private Limited | ₹1.03 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Pune, Maharashtra, India |
| Amritsar Neuro Psychiatric & Deaddiction Hospital Private Limited | ₹1.02 Cr (FY 2025) | •••• | •••• | 160.0% | •••• | Amritsar, Punjab, India |
| GP Aesthetics Private Limited | ₹1.02 Cr (FY 2024) | •••• | •••• | •••• | Gurugram, Haryana, India | |
| Marathwada Balrugnalay Private Limited | ₹1.02 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Nanded, Maharashtra, India |
| Umbicell Private Limited this company | ₹1.02 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Thane, Maharashtra, India |
| Sri Venkteshwara Indo Global Medicare Private Limited | ₹1.02 Cr (FY 2025) | •••• | •••• | 7007.0% | •••• | Mohali, Punjab, India |
| Ivd Solutions Private Limited | ₹1.02 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Faridabad, Haryana, India |
| Curatis Hospital & Healthcare Private Limited | ₹1.02 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Delhi, India |
| Punarvasu Aushadhshala Private Limited | ₹1.02 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Pune, Maharashtra, India |
| Oymom Health Private Limited | ₹1.02 Cr (FY 2024) | •••• | •••• | 103.0% | •••• | Nalanda, Bihar, India |
Peers are the five companies nearest above and the five nearest below Umbicell by revenue in the same principal business activity (Human health activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Umbicell Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Umbicell Private Limited
Umbicell Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Umbicell Private Limited
Employment history and EPFO contributions of people linked to Umbicell.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Umbicell Private Limited
Umbicell Private Limited has 6 board changes on record since 2017: 2 appointments and 4 cessations. The latest: Nisha Bhagatsingh Rajput ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Umbicell Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Umbicell Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Umbicell Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Umbicell Private Limited
Umbicell has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCU0533D1ZS | Maharashtra | Active | 01 Oct 2018 |
| 29AACCU0533D1ZO | Karnataka | Active | 14 Oct 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Umbicell Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Umbicell Private Limited
Umbicell is an active private limited company based in Thane, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 08 March 2017 (9+ years old) and is registered under CIN U24100MH2017PTC292167.
Umbicell reported revenue of ₹1.02 Cr for FY 2025 (down 9% YoY).
Umbicell has 2 current directors:
- Nisha Bhagatsingh Rajput - Director
- Varun Bhagat Singh Singh - Director
Umbicell reported a net profit of ₹48,766 (net margin 0.5%) and EBITDA of ₹1.76 Lakh (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Umbicell is 42% over three years and 45% over five years. In the latest year (FY 2025) revenue fell 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Umbicell is 27AACCU0533D1ZS, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AACCU0533D1ZO (Karnataka).
The CIN (Corporate Identification Number) of Umbicell is U24100MH2017PTC292167. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Umbicell was incorporated on 08 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Umbicell by revenue are Raj Homoeo Hall Private Limited, Well Care Real Solutions Private Limited, Amritsar Neuro Psychiatric & Deaddiction Hospital Private Limited, GP Aesthetics Private Limited, Marathwada Balrugnalay Private Limited and 5 more, all in the same principal business activity (Human health activities).
Nisha Bhagatsingh Rajput ceased to be Additional Director on 29 Sep 2024. Nisha Bhagatsingh Rajput was appointed as Director on 16 May 2024. Vyankatesh Jethmal Pidiyar ceased to be Additional Director on 16 May 2024. Umbicell has 6 board changes on record in total.
Yes, Umbicell is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).